Abstract
In our attempts to develop nucleoside analogues with selective antiviral activity we have envisaged the following targets : viral DNA polymerase (whether or not via viral dThd kinase), reverse transcriptase, AdoHcy hydrolase, dTMP synthetase, OMP decarboxylase and CTP synthetase